Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


06.08.2018

1 Ann Rheum Dis
1 Arthritis Res Ther
5 Clin Exp Rheumatol
2 Clin Rheumatol
1 Eur J Immunol
1 Intern Med
2 PLoS One
2 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. BUSTAMANTE MF, Oliveira PG, Garcia-Carbonell R, Croft AP, et al
    Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.
    Ann Rheum Dis. 2018 Jul 30. pii: annrheumdis-2018-213103.
    PubMed     Text format     Abstract available


    Arthritis Res Ther

  2. COHEN SB, Alten R, Kameda H, Hala T, et al
    A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.
    Arthritis Res Ther. 2018;20:155.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  3. ZABOTTI A, Mandl P, Zampogna G, Dejaco C, et al
    One year in review 2018: ultrasonography in rheumatoid arthritis and psoriatic arthritis.
    Clin Exp Rheumatol. 2018;36:519-525.
    PubMed     Text format     Abstract available

  4. ATTARD L, Tadolini M, De Rose DU, Cattalini M, et al
    Overview of fever of unknown origin in adult and paediatric patients.
    Clin Exp Rheumatol. 2018;36 Suppl 110:10-24.
    PubMed     Text format     Abstract available

  5. RUNOWSKA M, Majewski D, Niklas K, Puszczewicz M, et al
    Chikungunya virus: a rheumatologist's perspective.
    Clin Exp Rheumatol. 2018;36:494-501.
    PubMed     Text format     Abstract available

  6. BAULIER G, Issa N, Gabriel F, Accoceberry I, et al
    Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases.
    Clin Exp Rheumatol. 2018;36:490-493.
    PubMed     Text format     Abstract available

  7. TOLEDANO E, Ortiz AM, Ivorra-Cortes J, Montes N, et al
    Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study.
    Clin Exp Rheumatol. 2018;36:382-388.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  8. CANSU DU, Teke HU, Bodakci E, Korkmaz C, et al
    How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Clin Rheumatol. 2018 Jul 28. pii: 10.1007/s10067-018-4242.
    PubMed     Text format     Abstract available

  9. COLAK S, Sandikci SC, Gokmen D, Omma A, et al
    The relationship between bristol rheumatoid arthritis fatigue scales and disease activity of patients with rheumatoid arthritis.
    Clin Rheumatol. 2018 Jul 30. pii: 10.1007/s10067-018-4224.
    PubMed     Text format     Abstract available


    Eur J Immunol

  10. SUN J, Li L, Li L, Ding L, et al
    Metallothionein-1 suppresses rheumatoid arthritis pathogenesis by shifting the Th17/Treg balance.
    Eur J Immunol. 2018 Jul 28. doi: 10.1002/eji.201747151.
    PubMed     Text format     Abstract available


    Intern Med

  11. NAWATA T, Kubo M, Mitsui H, Oishi K, et al
    A Case of Dermatomyositis Complicated by Digital Ischemia and Lung Adenocarcinoma in a Patient with Positive Anti-signal Recognition Particle Antibodies.
    Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.9307.
    PubMed     Text format     Abstract available


    PLoS One

  12. LINDNER MD, Torralba KD, Khan NA
    Scientific productivity: An exploratory study of metrics and incentives.
    PLoS One. 2018;13:e0195321.
    PubMed     Text format     Abstract available

  13. LIU M, Degner J, Davis JW, Idler KB, et al
    Identification of HLA-DRB1 association to adalimumab immunogenicity.
    PLoS One. 2018;13:e0195325.
    PubMed     Text format     Abstract available


    Rheumatol Int

  14. YU X, Li Z, Ren M, Xi J, et al
    Superb microvascular imaging (SMI) for evaluating hand joint lesions in patients with rheumatoid arthritis in clinical remission.
    Rheumatol Int. 2018 Jul 30. pii: 10.1007/s00296-018-4112.
    PubMed     Text format     Abstract available

  15. SAWADA H, Suda M, Rokutanda R, Kobayashi D, et al
    Concomitant use of intravenous methylprednisolone to increase retention rate of abatacept in rheumatoid arthritis.
    Rheumatol Int. 2018 Jul 27. pii: 10.1007/s00296-018-4115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: